Gaudium IVF and Women Health Ltd - 544709 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Gaudium IVF & Women Health will conduct a virtual meet with analysts and institutional investors on June 12, 2026. The discussions will be based on publicly available information, and no unpublished price sensitive information will be shared.
Jun 08 2026 19:53:43
Gaudium IVF and Women Health Ltd - 544709 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Gaudium IVF & Women Health made the audio recording of its Q4 FY26 earnings call available. This provides investors access to management commentary on the financial results for the quarter and year ended March 31, 2026.
May 29 2026 16:03:19
Gaudium IVF and Women Health Ltd - 544709 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Gaudium IVF announced its Q4 FY26 audited financial results via a press release, showing revenue growth of 13% YoY to Rs.30.35 cr and net profit increasing 30% YoY to Rs.8.36 cr. The full FY26 saw revenue rise 48% YoY to Rs.104.35 cr and PAT grow 28% YoY to Rs.24.48 cr, driven by operational efficiencies.
May 29 2026 01:58:44
Gaudium IVF and Women Health Ltd - 544709 - Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31, 2026
Gaudium IVF's Board approved audited consolidated Q4 FY26 financial results, reporting revenue of ₹30.35 crore and net profit of ₹8.36 crore. For the full fiscal year 2026, consolidated revenue was ₹104.36 crore and net profit ₹24.49 crore. The trading window remains closed until May 30, 2026.
May 28 2026 19:57:55
Gaudium IVF and Women Health Ltd - 544709 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Gaudium IVF & Women Health announced that the NCLT, New Delhi Bench, rejected an insolvency petition filed by an Operational Creditor. This favorable order, received on May 22, 2026, ensures no impact on the company's financial or operational activities.
May 23 2026 14:22:52
Gaudium IVF and Women Health Ltd - 544709 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Audited Standalone And Consolidated Financial Statements/Results Of The Company For The Quarter And Year Ended March 31, 2026.
Gaudium IVF & Women Health's board will convene on May 28, 2026. The primary agenda is to consider and approve the audited standalone and consolidated financial results for the fourth quarter and full financial year ending March 31, 2026.
May 22 2026 17:47:58
Read More